Patents by Inventor Aurelie MALLINGER

Aurelie MALLINGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS
    Publication number: 20220144815
    Abstract: The present disclosure relates to the use of 1,3,4-oxadiazoles and derivatives thereof as fungicide. It also relates to new 1,3,4-oxadiazoles derivatives, their use as fungicide and compositions comprising thereof.
    Type: Application
    Filed: December 20, 2019
    Publication date: May 12, 2022
    Inventors: Stephane BRUNET, Pierre-Yves COQUERON, Philippe DESBORDES, Sophie DUCERF, Jeremy DUFOUR, Andreas GOERTZ, Emmanuelle HILT, Aurelie MALLINGER, Sebastien NAUD, Anne-Sophie REBSTOCK, Vincent THOMAS
  • Pyridyl piperidines
    Patent number: 9926319
    Abstract: The invention provides novel substituted pyridyl piperidine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: March 27, 2018
    Assignees: MERCK PATENT GMBH, Cancer Research Technology Limited
    Inventors: Kai Schiemann, Frank Stieber, Michel Calderini, Julian Blagg, Aurelie Mallinger, Dennis Waalboer, Christian Rink, Simon Ross Crumpler
  • Indazoles
    Patent number: 9862717
    Abstract: The invention provides novel substituted indazole compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Grant
    Filed: July 30, 2015
    Date of Patent: January 9, 2018
    Assignees: Merck Patent GmbH, Cancer Research Technology Limited
    Inventors: Kai Schiemann, Aurelie Mallinger
  • 2-aminopyridine compounds
    Patent number: 9834541
    Abstract: The invention provides novel substituted 2-aminopyridine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: December 5, 2017
    Assignees: CANCER RESEARCH TECHNOLOGY LIMITED, MERCK PATENT GMBH
    Inventors: Kai Schiemann, Frank Stieber, Julian Blagg, Aurelie Mallinger, Dennis Waalboer, Christian Rink, Simon Ross Crumpler
  • INDAZOLES
    Publication number: 20170267675
    Abstract: The invention provides novel substituted indazole compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Application
    Filed: July 30, 2015
    Publication date: September 21, 2017
    Applicants: Merck Patent GmbH, Cancer Research Technology Ltd.
    Inventors: Kai SCHIEMANN, Aurelie MALLINGER
  • PYRIDYL PIPERIDINES
    Publication number: 20170107222
    Abstract: The invention provides novel substituted pyridyl piperidine compounds according to Formula (I) which are Wnt pathway inhibitors, their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Application
    Filed: March 10, 2015
    Publication date: April 20, 2017
    Applicants: MERCK PATENT GMBH, Cancer Research Technology Limited
    Inventors: Kai SCHIEMANN, Frank STIEBER, Michel CALDERINI, Julian BLAGG, Aurelie MALLINGER, Dennis WAALBOER, Christian RINK, Simon Ross CRUMPLER
  • NOVEL NAPHTHYRIDINES AND ISOQUINOLINES AND THEIR USE AS CDK8/19 INHIBITORS
    Publication number: 20160016951
    Abstract: The present invention relates to naphthyridine and isoquinoline compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of CDK8/19, and for the treatment of CDK8/19-related disorders.
    Type: Application
    Filed: July 17, 2015
    Publication date: January 21, 2016
    Inventors: Kai SCHIEMANN, Julian BLAGG, Aurelie MALLINGER, Christian RINK, Jimmy SEJBERG, Mark HONEY
  • 2-AMINOPYRIDINE COMPOUNDS
    Publication number: 20150353548
    Abstract: The invention provides novel substituted 2-aminopyridine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
    Type: Application
    Filed: October 2, 2013
    Publication date: December 10, 2015
    Applicants: CANCER RESEARCH TECHNOLOGY LIMITED, MERCK PATENT GMBH
    Inventors: Kai SCHIEMANN, Frank STIEBER, Julian BLAGG, Aurelie MALLINGER, Dennis WAALBOER, Christian RINK, Simon Ross CRUMPLER